AMPIMAST syringae intramammariae 10 g
AMPIMAST syringae intramammariae 10 g
Not authorised
- Oxacillin sodium
- Ampicillin sodium
Product identification
Medicine name:
AMPIMAST syringae intramammariae 10 g
Active substance:
- Oxacillin sodium
- Ampicillin sodium
Target species:
-
Cattle
-
Sheep
-
Goat
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Oxacillin sodium155000.00/international unit(s)1.00Syringe
-
Ampicillin sodium300000.00/international unit(s)1.00Syringe
Pharmaceutical form:
-
Intramammary ointment
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle
-
Meat and offal7day
-
Milk72hourМляко: 72 часа за третирани млечни четвъртини/ половини. : 24 часа за нетретирани млечни четвъртини/ половини
-
-
Sheep
-
Meat and offal7dayМляко: 72 часа за третирани млечни четвъртини/ половини. : 24 часа за нетретирани млечни четвъртини/ половин
-
-
Goat
-
Meat and offal7dayМляко: 72 часа за третирани млечни четвъртини/ половини. : 24 часа за нетретирани млечни четвъртини/ половин
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51CA51
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Bulgaria
Package description:
- Available only in Bulgarian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
- Vetprom AD
Marketing authorisation date:
Manufacturing sites for batch release:
- Vetprom AD
Responsible authority:
- Bulgarian Food Safety Authority
Authorisation number:
- 0022-2322-25.06.2014
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 31/05/2022